Hims & Hers vs Walgreens

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (86 vs 83)
Hims & Hers logo

Hims & Hers

EmergingHealthcare

Telehealth Pharmacy

Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.

AI VisibilityBeta
Overall Score
A86
Category Rank
#8 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
92
Gemini
83

About

Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.

Full profile
Walgreens logo

Walgreens

LeaderHealthcare

Pharmacy Retail

NASDAQ-listed (WBA) US pharmacy giant with 8,700 stores going private via Sycamore Partners LBO in 2024; major restructuring after 70% stock decline, clinic write-downs, and dividend cuts.

AI VisibilityBeta
Overall Score
A83
Category Rank
#13 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
80
Gemini
86

About

Walgreens Boots Alliance (NASDAQ: WBA) is the largest US pharmacy chain and global pharmacy-led health and wellness company — operating approximately 8,700 Walgreens locations in the US alongside Boots pharmacies in the UK and other international markets, providing prescription medications, over-the-counter health products, beauty items, and health clinic services through the largest drugstore footprint in the US. WBA generated $147 billion in revenue in fiscal year 2024 and serves approximately 9 million customers daily, making it one of the most visited retail destinations in the US.

Full profile

AI Visibility Head-to-Head

86
Overall Score
83
#8
Category Rank
#13
79
AI Consensus
83
stable
Trend
stable
88
ChatGPT
84
92
Perplexity
80
83
Gemini
86
90
Claude
80
89
Grok
80

Key Details

Category
Telehealth Pharmacy
Pharmacy Retail
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Hims & Hers
Telehealth Pharmacy
Only Walgreens
Pharmacy Retail

Integrations

Only Walgreens
Walgreens is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.